OR WAIT null SECS
In a segment of his HCPLive interview regarding his Winter Clinical presentation, James Del Rosso, DO, highlighted several points about acne and rosacea treatment.
During his recent interview on HCPLive, JAmes Q. Del Rosso, DO, described several major talking points from his 2023 Winter Clinical Dermatology conference presentation titled ‘What's New in the Medicine Chest, Part II.’
In the presentation itself, he covers a wide array of updates on dermatologic conditions including acne, rosacea, actinic keratoses, psoriasis, urticaria, and several other common dermatoses.
Del Rosso works as both a dermatologist and as the research director of JDR Dermatology Research in Las Vegas, Nevada.
“I've had the responsibility for some time now to do ‘What's New in the Medicine Chest, Part 1’ and Part 2,” he explained. “And that gives me the opportunity to look at a variety of different areas. And my focus is really to be looking at many different disease states from an educational standpoint, understanding the disease, and then understanding the management.”
He explained that his work involves a lot of both clinical research and treatment of patients. Del Rosso explained that he then takes his information and translates it for clinicians to use in their clinical practices.
“And I've been involved in a variety of different areas, acne and rosacea are 2, and we sort of lumped them together but they are indeed very, very different,” he said. “So, what I did talk about here, specifically with regard to rosacea, is really how to look at the disease state. And when you're seeing the patient at that point in time, what are they presenting? What are the visible features of it, but also the symptomatology that they might have?”
Del Rosso explained that it may be useful to get the sequence of what patients have been facing and what they have used thus far, before then looking at their condition and characterizing what to target.
“So we're talking about rosacea, most of the time, you know, cutaneous rosacea is what we're talking about,” he said. “You could have ocular rosacea, you could have rosacea also involving the eyes, which is important to find out about. But on the skin, patients will have central facial erythema that will worsen with periods of flaring—so called flushing—but it's vasodilation.”
Del Rosso further explained the difficulty in differentiating rosacea from other conditions when examining patients, adding that photoprotection is crucial for patients to eliminate redness that would be otherwise attributable to sun exposure.
For more information on Del Rosso’s Winter Clinical presentation, watch the full segment above.